Challenging the validity of imposing contraindications to thrombolysis for acute ischemic stroke

Bart M. Demaerschalk

doi:10.1212/WNL.0b013e318238eee8

Challenging the validity of imposing contraindications to thrombolysis for acute ischemic stroke

Bart M. Demaerschalk

Neurology

Research output: Contribution to journal › Editorial › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	1862-1863
Number of pages	2
Journal	Neurology
Volume	77
Issue number	21
DOIs	https://doi.org/10.1212/WNL.0b013e318238eee8
State	Published - Nov 22 2011

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/WNL.0b013e318238eee8

Cite this

@article{0cd7258bcb8344aabef38dc814f1d832,

title = "Challenging the validity of imposing contraindications to thrombolysis for acute ischemic stroke",

author = "Demaerschalk, {Bart M.}",

note = "Funding Information: Dr. Demaerschalk serves on the editorial boards of Stroke, Journal of Stroke and Cerebrovascular Diseases, Hospital Practice , and Open Critical Care Medicine Journal, and as Section Editor for The Neurologist ; and receives/has received research support from AGA Medical Corporation, Vernalis, Mitsubishi Tanabe Pharma Corporation, Abbott, Penumbra, Inc., Axio Research, Neuralieve Inc., Genentech, Inc., the Arizona Department of Health Services, the National Stroke Association, and the NIH/NINDS. ",

year = "2011",

month = nov,

day = "22",

doi = "10.1212/WNL.0b013e318238eee8",

language = "English (US)",

volume = "77",

pages = "1862--1863",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "21",

}

TY - JOUR

T1 - Challenging the validity of imposing contraindications to thrombolysis for acute ischemic stroke

AU - Demaerschalk, Bart M.

N1 - Funding Information: Dr. Demaerschalk serves on the editorial boards of Stroke, Journal of Stroke and Cerebrovascular Diseases, Hospital Practice , and Open Critical Care Medicine Journal, and as Section Editor for The Neurologist ; and receives/has received research support from AGA Medical Corporation, Vernalis, Mitsubishi Tanabe Pharma Corporation, Abbott, Penumbra, Inc., Axio Research, Neuralieve Inc., Genentech, Inc., the Arizona Department of Health Services, the National Stroke Association, and the NIH/NINDS.

PY - 2011/11/22

Y1 - 2011/11/22

UR - http://www.scopus.com/inward/record.url?scp=82955228890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82955228890&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e318238eee8

DO - 10.1212/WNL.0b013e318238eee8

M3 - Editorial

C2 - 22094485

AN - SCOPUS:82955228890

SN - 0028-3878

VL - 77

SP - 1862

EP - 1863

JO - Neurology

JF - Neurology

IS - 21

ER -

Challenging the validity of imposing contraindications to thrombolysis for acute ischemic stroke

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this